Immutep (IMMP) Earnings Date & Reports

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

IMMP is expected to report earnings to fall 13.50% to -15 cents per share on August 30

Q2'22

Est.

$-0.16

Q4'23

Missed

by $0.05

Q2'23

Est.

$-0.15

Q4'22

Beat

by $0.01

The last earnings report on February 27 showed earnings per share of -18 cents, missing the estimate of -13 cents. With 126.09K shares outstanding, the current market capitalization sits at 240.70M.

View a ticker or compare two or three

Compare

IMMP

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For IMMP
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of anti-cancer therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

264 George Street

Phone

+61 283157003

Employees

Web

https://www.immutep.com